Find a Commonwealth Resource
Inotuzumab ozogamicin
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Besponsa (inotuzumab ozogamicin) is an intravenous prescription drug, supplied as a lyophilized powder for injection. It's an immunoconjugate that targets CD22 on cancer cells, leading to DNA damage and cell death. Manufactured by Wyeth Pharmaceuticals LLC (a Pfizer subsidiary), it's used in treating relapsed or refractory acute lymphoblastic leukemia. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Inotuzumab ozogamicin
Access the FDA dataset for Inotuzumab ozogamicin — ANDA 203308 submitted by Mylan Institutional LLC
Modified Mar 24, 2026